Archive for the ‘Commercialization’ Category

BRM2017: State of the regenerative medicine industry

Author: Stacey Johnson, 08/09/17

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His graduate research at Queen’s University, where he is pursuing a PhD in Chemical…Read more

Congratulations, you graduated this year! So, what happens next?

Author: Hamideh Emrani, 07/20/17

Passing by university campuses in the month of June, what you will notice is joyful, well dressed students, accompanied by family members, attending their graduation ceremonies. It is indeed a great feeling to have accomplished a university degree after a lot of dedication and hard work. I personally prefer the name commencement instead of graduation…Read more

Right Turn: Primers on cell therapy regulation

Author: Stacey Johnson, 06/16/17

Understanding cell therapy regulation is an essential component of the bench to bedside pipeline. Without approval from a country’s regulator (Health Canada, FDA, EMA, PMDA, etc.), a product cannot be sold to consumers and the millions invested in research and development, manufacturing and clinical trials is media down the drain. Cell therapies present a range…Read more

Right Turn: Stem cell “gun” for wound healing

Author: Stacey Johnson, 06/02/17

It has been said that the pen is mightier than the sword. Where, then, does the gun factor in? I was amazed, last year, when I learned of the “biopen,” a medical device that draws stem cells to repair damaged or worn cartilage and then the cartilage heals itself with its own cells. From what…Read more

Five regenerative medicine workshops to attend this summer

Author: Guest, 05/15/17

Amin Adibi is a biomedical engineer and a health data analyst at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for…Read more

Funding the future: Highlights from Bloom Burton & Co.’s Healthcare Investor Conference

Author: Guest, 05/04/17

Samantha Yammine is a PhD Candidate in Dr. Derek van der Kooy’s lab at the University of Toronto studying how stem cells develop and maintain the brain. Samantha is passionate about science advocacy, policy, and education, and is an avid science communicator. You can find her sharing science straight from the lab on Instagram (@science.sam),…Read more

Filling the void: A scientist’s introduction to commercialization/clinical translation

Author: Holly Wobma, 04/26/17

For anybody who has invested a great deal of time into a research project, you probably feel a certain sense of expertise on the topic. Sure, it is impossible to know a whole field (every answer raises more questions), and lab work is rife with puzzlement and failures, but at the end of the day,…Read more

Right Turn: Sightings of innovation in Canada

Author: Stacey Johnson, 04/14/17

If you are a knowledge worker, it may seem as though “innovation” is on everyone’s lips these days. First, Canadians saw Industry Canada renamed Innovation, Science and Economic Development when Prime Minister Trudeau unveiled his first cabinet. Then, Budget 2017, titled “building a strong middle class” could have had “the innovation budget” as its working…Read more

The long slog of medical R&D and finding inspiration

Author: Elizabeth Csaszar, 03/27/17

Research and development (R&D) of a medical therapeutic is a long slog. This isn’t news to anyone working in the field. The average time to bring a new drug product to market is over a decade. Moreover, this is the timeline when everything progresses well – funding and business decisions align, manufacturing processes come together,…Read more

Improving ultrasound imaging may have applications in regenerative medicine

Author: Guest, 03/13/17

Andy Bell, a writer working with Toronto3dprinting, loves to write about different topics related to technological gadgets and gears. 3D printing is his current interest. Though ultrasound technology is commonly associated with the imaging of fetuses in the womb, its applications are much more than just imaging. The acoustic waves generated by ultrasound devices can…Read more